Concentra Group Holdings Q4 2024 Earnings Report
Key Takeaways
Concentra reported a 5.5% increase in revenue for Q4 2024, reaching $465.0 million, and a net income of $22.8 million. The company also completed the acquisition of Nova Medical Centers, expanding its footprint in occupational health services.
Revenue increased by 5.5% to $465.0 million compared to Q4 2023.
Net income was $22.8 million, with earnings per share of $0.17.
Adjusted EBITDA increased by 13.6% to $77.5 million compared to Q4 2023.
The acquisition of Nova Medical Centers was completed, expanding the company's occupational health services.
Concentra Group Holdings
Concentra Group Holdings
Concentra Group Holdings Revenue by Segment
Forward Guidance
Concentra provided its 2025 financial outlook, anticipating revenue of approximately $2.1 billion and adjusted EBITDA in the range of $410 million to $425 million, inclusive of the Nova Medical Centers acquisition.
Positive Outlook
- Revenue of approximately $2.1 billion
- Adjusted EBITDA in the range of $410 million to $425 million
- Capital expenditures in the range of $80 million to $90 million
- Net leverage ratio of approximately 3.5x
- Strong business performance in 2024 positions the Company well for continued growth